Sung did a
good job on his oral presentation of the thesis project; Carl's coaching had
been taken seriously. The presentation was organized in a logical and obvious
fashion. Sung stood confidently and enunciated slowly and carefully. The
questioning began relatively benignly; Dr. Karesh asked about the turnover time
of the tumor line that Sung was using, which led to more general questions on
cell cycle kinetics and how cell cycle data were obtained and analyzed. Next
came a question on the antigenicity of the tumor line and whether or not it
secreted substantial amounts of antigen into the culture medium. Carl had
forseen these questions and Sung was prepared to answer them. In fact, he was
so well prepared that his answers sounded as if he were reading them from
notes. Carl wondered, absently, whether Sung had taken the questions Carl had
given him, written out answers to them, and memorized the written answers.
Then Dr. Munster asked, "Why
are you using the B-14 tumor line for your studies?"
Sung looked baffled, glanced around
at Carl, then said, "I use B-14 tumor line in laboratory."
"Yes, but why do you
use it," pursued Munster .
"It is tumor line,"
answered Sung.
Carl could not refrain from
responding. "Otto, it's a fast-growing tumor line that can be made to slow
and differentiate by a variety of agents. It's an ideal tumor line for his
problem."
"Two year," came the
reply.
"And after two years, you
still don't know the plural of year?" enunciated Munster with Germanic precision.
Sung was baffled, not knowing
whether that had been a question, nor whether he was expected to answer it.
"Two yearrss," he said with effort, the "r" and
"s" sounds rolling in awkward succession off his stiffened tongue and
out his pursed lips.
"In the two years that you've
been working with it, has the cell line changed?" continued Munster .
"No," said Sung Lee
With Sung's definite
"NO." Carl knew that the difficult questioning was about to begin,
and he felt a sense of helplessness as he foresaw Sung sinking deeper and
deeper into a quicksand
of inadequate answers resulting from his
failure to perceive the intent
behind a question.
"How do you know the cell line
hasn't changed?" pursued Munster .
"It has same antigen,"
responded Sung, ready with an answer and regaining a bit of confidence.
"Is surface antigenicity the
only criterion for identifying a cell type? Could there be antigens on the cell
surface now that weren't there two years ago and that you haven't assayed for?
What about other criteria for identification? Have you karyotyped the line
recently? Have you checked metabolic pathways?"
After this barrage of questions,
Sung hesitated a moment and finally said, "No." Another hesitation.
He glanced at the blank projector screen, then at the blackboard, began walking
toward it, stopped, and then turned back toward the expectant faces before him.
He moved his mouth a bit as if intending to say something but, apparently
thinking better of it, remained silent. He put his hands on the podium and a
blank expression came over his face as he stared over the heads of the
examiners.
"No? No, what," queried Munster incredulously. "Have you not
checked metabolic pathways? Did you not do karyotyping? Do you not
know whether or not your cell line has changed?"
"No," responded Sung,
still staring at the back wall of the conference room, his face reddening.
"I have no further questions
for the time being," said Munster, turning to Carl.
_________
For the next installment, click here.
_________
For the next installment, click here.
No comments:
Post a Comment